(0.33%) 5 116.55 points
(0.32%) 38 363 points
(0.37%) 15 987 points
(-0.97%) $83.04
(5.25%) $2.02
(0.32%) $2 354.70
(0.49%) $27.67
(4.10%) $959.95
(-0.27%) $0.932
(-0.48%) $10.97
(-0.58%) $0.796
(1.66%) $93.40
Live Chart Being Loaded With Signals
Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform...
Stats | |
---|---|
本日の出来高 | 23 223.00 |
平均出来高 | 158 719 |
時価総額 | 31.98M |
EPS | $0 ( 2024-03-07 ) |
次の収益日 | ( $-0.0700 ) 2024-05-16 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -1.220 |
ATR14 | $0.00400 (0.63%) |
Evogene Ltd 相関
10 最も負の相関 | |
---|---|
EPZM | -0.922 |
CNCE | -0.906 |
XOG | -0.898 |
LMNL | -0.869 |
TLMD | -0.868 |
TYHT | -0.867 |
RESN | -0.862 |
SIVBP | -0.85 |
CNST | -0.849 |
FIZZ | -0.847 |
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Evogene Ltd 相関 - 通貨/商品
Evogene Ltd 財務諸表
Annual | 2023 |
収益: | $5.64M |
総利益: | $1.40M (24.80 %) |
EPS: | $-0.520 |
FY | 2023 |
収益: | $5.64M |
総利益: | $1.40M (24.80 %) |
EPS: | $-0.520 |
FY | 2022 |
収益: | $1.68M |
総利益: | $766 000 (45.73 %) |
EPS: | $-0.720 |
FY | 2021 |
収益: | $930 000 |
総利益: | $163 000 (17.53 %) |
EPS: | $-0.690 |
Financial Reports:
No articles found.
Evogene Ltd
Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding of biology leveraged through big data and artificial intelligence, designed to computationally discover and uniquely guide the development of life-science products based on microbes, small molecules, and genetic elements. The company operates through three segments: Agriculture, Human Health, and Industrial Applications. The Agriculture segment develops seed traits, ag-chemical products, and ag-biological products to enhance plant performance. Its products focus on various crops, such as corn, soybean, wheat, rice, and cotton. The Industrial Applications segment develops enhanced castor bean seeds to serve as a feedstock source for other industrial uses. The Human Health segment discovers and develops human microbiome-based therapeutics for the treatment of immuno-oncology, GI related disorders, and antimicrobial resistance organisms. The company also provides medical cannabis products. It operates in the United States, Israel, Brazil, and internationally. The company has strategic collaborations and licensing agreements with agricultural companies, such as BASF SE, Corteva, and Bayer; and through its subsidiary, Canonic Ltd., has a collaboration agreement with Cannbit Ltd. for the development of novel medical cannabis products. Evogene Ltd. was founded in 1999 and is headquartered in Rehovot, Israel.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。